RxDoctor Payments Data

Maxine Klempner

Long Island City, NYNPI 1699550673

Payments from drug & device makers

$4,586in general payments, 2019–2025

Across 173 payments — averaging $26.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • UCB, Inc.$567
  • LEO Pharma Inc.$527
  • Novartis$497
  • Regeneron Healthcare Solutions, Inc.$475
  • Lilly USA, LLC$351
  • plus $870 from 9 others

What the payments were for

  • Food & beverage$4,50598%
  • Education$812%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate68$6,362
Tacrolimus16$2,677
Ketoconazole47$1,237
Minoxidil34$971
Tretinoin14$866
Ammonium Lactate27$402
Triamcinolone Acetonide34$391
Mupirocin36$194
Permethrin12$168
Hydrocortisone18$150

Paid to pharmacies, not to this prescriber.

Where these figures come from

Is this you, or does something look wrong? →